A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

NCT07746817 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Healthy Participants

Interventions

BIOLOGICAL: BYN-001
DRUG: Placebo

Sponsor

Bionyra Pharma